Maegim

Stock search

Search by company name, 6-digit code, or Korean initials (e.g. ㅅㅅㅈㅈ)

한국어

IMBdx, Inc.

아이엠비디엑스461030KOSDAQSector: Pharma & Biotech
₩3,0050.83%Market cap ₩43.1BAs of Sep 1, 2026 close · updated once daily
Market cap
₩43.1B
#1221 in KOSDAQ
Loss
PER not computable
1.71x
Sector median 1.61x
0.0%
Sector median 0.0%
B
Grade B52.1 ptsTop 50% of 2,523 graded stocksMethodology v2.0

As of Sep 1, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

How to read this grade
SABCurrentCDF

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,523 graded stocks and is currently in band B with a total score of 52.1 points.

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 250 stocks in Pharma & Biotech

1-year closing price

Loading closing price history…
 
Low ₩2,595High ₩12,080
Latest close
Price change by period
1W
1.40%
1M
3.00%
3M
33.50%
1Y
61.60%

As of the Sep 1, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

1

Financial strength

57.5/100
How much debt does it carry relative to equity?
7.8%
Sector median 51.6%
Sector lowhighTop 7.9% in sector
Can it cover what's due within a year?
1537.0%
Sector median 191.7%
Sector lowhighTop 9.1% in sector
How much of revenue becomes profit?
-162.6%
Sector median -2.4%
Sector lowhighBottom 21.5% in sector
How much did it earn on its own capital?
-31.5%
Sector median -4.5%
Sector lowhighBottom 25.3% in sector

Source filing: annual report (separate) — view original

2

Growth momentum

74.7/100
How much did revenue grow in a year?
56.4%
Sector median 6.4%
Sector lowhighTop 13% in sector
Did core profits grow in a year?
18.4%
Sector median 3.6%
Sector lowhighTop 37.6% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (separate) — view original

3

Price attractiveness

32.0/100
Is the price expensive relative to earnings?
Loss-making (P/E not computable)
Sector median P/E of profitable peers 16.3x · 58% loss-making
Sector lowhighBottom 16.4% in sector
Is the price expensive relative to book value?
1.71x
Sector median 1.61x
Sector lowhighBottom 47.6% in sector

Valuation uses the Sep 1, 2026 close and market cap

4

Shareholder Return

Single-indicator axis37.5/100
Does the company actually pay dividends?
0.0%
Sector median 0.0%
Sector lowhighBottom 37.5% in sector

Source filing: annual report (separate) — view original

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 2, 2026

Of 9 items: 3 met · 4 not met · 2 not computable

Not metMetNot computable

Positive net income
Whether net income (attributable to owners where available) is above zero.
Not met
-₩7.9B
Positive operating cash flow
Whether cash flow from operations is above zero.
Not met
-₩6.2B
Return on assets up
Whether net income over beginning total assets rose from the prior year.
Not computable

Not computed — required financial data is unavailable

Operating cash flow exceeds net income
Whether operating cash flow is greater than net income.
Met
-₩6.2B vs -₩7.9B
Liabilities-to-assets ratio down
Whether total liabilities as a share of total assets fell from the prior year.
Not met
4.7% → 7.2%
Current ratio up
Whether current assets over current liabilities rose from the prior year.
Not met
2596.9% → 1537.0%
Shares outstanding not increased
Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.
Met
14,017,750 → 14,017,750
Operating margin up
Whether operating income over revenue rose from the prior year.
Met
-311.5% → -162.6%
Asset turnover up
Whether revenue over beginning total assets rose from the prior year.
Not computable

Not computed — required financial data is unavailable

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (separate) — view original

Grade change history

Jul 23, 2026B

Methodology version change (v2.0 applied)

Jul 15, 2026BVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Recent filings for this stock

Last 120 days · monitored filing types only
Periodic report filedAug 14, 2026Source
Periodic report filedMay 15, 2026Source

View in the filings calendar →